Viatris and Idorsia seal research and development deal for two phase III assets
SWITZERLAND — Swiss pharmaceutical company Idorsia has recently secured a vital financial lifeline...
Read MoreSelect Page
by Editor | Mar 2, 2024 | LATEST NEWS, WORLD NEWS | 0
SWITZERLAND — Swiss pharmaceutical company Idorsia has recently secured a vital financial lifeline...
Read Moreby Editor | Nov 29, 2023 | AFRICAN & MIDDLE EAST NEWS, Government, Regulatory & Policy News, Hospitals, LATEST NEWS | 0
UAE – The Department of Health – Abu Dhabi (DoH) and Viatris have linked up to introduce an...
Read Moreby Editor | Oct 3, 2023 | LATEST NEWS, Mergers, Investments & Funding, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
USA — Viatris has unveiled plans to sell several assets, including a significant portion of its...
Read Moreby Editor | Sep 7, 2023 | LATEST NEWS, Mergers, Investments & Funding, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
INDIA – Biocon Biologics has finalized the integration of the acquired biosimilars business from...
Read Moreby Editor | Aug 13, 2023 | LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
USA — Viatris Pharmaceuticals is currently awaiting regulatory verdicts on its generic versions of...
Read Moreby Editor | Mar 21, 2023 | LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
USA — Rival drugmakers Merck and Viatris have reached an agreement in their patent dispute over...
Read More